tiprankstipranks
Valeo Pharma Inc (VPHIF)
:VPHIF
US Market

Valeo Pharma (VPHIF) Income Statement

Compare
14 Followers

Valeo Pharma Income Statement

Last quarter (Q3 2024), Valeo Pharma's total revenue was C$12.60M, a decrease of -10.52% from the same quarter last year. In Q3, Valeo Pharma's net income was C$-8.19M. See Valeo Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 53.91MC$ 27.75MC$ 13.56MC$ 7.47MC$ 6.58M
Gross Profit
C$ 13.08MC$ 6.28MC$ 3.96MC$ 1.38MC$ 1.40M
Operating Expenses
C$ 30.30MC$ 25.39MC$ 16.65MC$ 5.68MC$ 5.14M
Depreciation and Amortization
C$ 2.63MC$ 1.42MC$ 743.00KC$ 424.00KC$ 135.00K
EBITDA
C$ -11.39MC$ -17.56MC$ -11.86MC$ -3.74MC$ -3.41M
Operating Income
C$ -17.23MC$ -19.60MC$ -12.94MC$ -4.12MC$ -3.54M
Other Income/Expenses
C$ -10.58MC$ -7.32MC$ -1.42MC$ -644.00KC$ 122.00K
Pretax Income
C$ -27.81MC$ -26.92MC$ -14.23MC$ -4.76MC$ -3.62M
Net Income
C$ -27.81MC$ -25.75MC$ -14.23MC$ -4.76MC$ -3.62M
Per Share Metrics
Basic EPS
C$ -0.32C$ -0.32C$ -0.20C$ -0.08C$ -0.07
Diluted EPS
C$ -0.32C$ -0.32C$ -0.20C$ -0.08C$ -0.07
Weighted Average Shares Outstanding
86.12M 80.86M 69.93M 57.91M 49.59M
Weighted Average Shares Outstanding (Diluted)
86.12M 80.86M 69.93M 57.91M 49.59M
Currency in CAD

Valeo Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis